EPAD presented at the Alzheimer Europe Academy

On 5 and 6 December 2017, Alzheimer Europe (AE) hosted its third annual Alzheimer’s Association Academy in Brussels, Belgium. The meeting was attended by 49 participants including representatives from AE member organisations, national Alzheimer associations and company. There were 14 expert speakers on the packed agenda. The two-day Academy was a highly interactive event, with lots of…

EPAD opens six new study sites

The European Prevention of Alzheimer’s Dementia Consortium (EPAD) is recruiting research participants at six new sites, bringing the total to ten centres in six European countries. People in France, the Netherlands, Spain, Sweden, Switzerland and UK can now take part in the study, which aims to develop tests to identify early signs of Alzheimer’s disease…

Members of the EPAD communication team meet to update the project’s communication strategy

On 20 November, members of the EPAD WP6 communication team held a one day meeting in Amsterdam to update the communication plan for the final two years of the project. The team discussed the updated project’s communication strategy, focus plan and activities for 2018-2019. The participants started to review the communication activities undertaken from 2015-2017.…

Interview with Lea ter Meulen

What is your current role in EPAD? I wear two hats within EPAD. Firstly I work for WP3, which is led by Pieter Jelle Visser at VUmc and Gerald Luscan at Pfizer. Together with a great team of colleagues, I’m involved in the process of informing new cohorts and getting them connected to the Registry.…

Interview with Gary Romano

What is your current role in EPAD? I am a member of the Executive committee, the CDEx clinical Mitterrand and balancing committee.   What did you do prior to joining EPAD? I have been working in neuroscience drug development for nearly 16 years, at Merck and at Janssen.      Tell us a bit about…